Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol PK in Asthmatics and Athletes
NCT00914901Phase 4Unknown
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Jul 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of salmeterol in asthma (3 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Serum and urine concentrations of salmeterol at 12 hours. Status: unknown.
02
Drugs
salmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00914901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00914901.